Banks, Telecommunications Services, and Capital Goods Among

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
42
Banks, Telecommunications Services, and Capital Goods Among Most Competitive in Institutional Investor's 2017 All-Europe Executive Team Rankings

LONDON, UNITED KINGDOM--(Marketwired - Mar 21, 2017) -   Institutional Investor is pleased to announce the results of the 2017 rankings of Europe's top CEOs, CFOs, Investor Relations Officers, and Investor Relations programs. This year 2,594 investment professionals globally, up from 1,664 in the previous year, voted in the All-Europe Executive Team survey, nominating 2,961 officers from 1,513 companies across 31 sectors. The IR programs were evaluated on six performance criteria, including accessibility of senior management, authoritative IR, and transparency of financial reporting.

Research from Institutional Investor shows three clear themes emerge this year:

  • Changes to both the buy and sell side in anticipation of MiFID II mean that strong IR programs relative to peer companies as an indicator of likely success in investor engagement are increasingly important.
  • Small- and mid-cap companies saw significantly increased voting, suggesting they are responding to new regulatory pressures, becoming more proactive and as a result an increasingly important value play for investors. This has led to a new mid-/small-cap ranking across sectors this year.
  • Effective and timely financial disclosure remains investors' No. 1 priority for IR activities.

Thirteen companies sweep their sectors -- capturing first place in every category in which they are eligible to compete. Repeating last year's success are Airbus , Anheuser-Busch InBev, Deutsche Telekom , Iberdrola , and Reckitt Benckiser Group. New to this year's top performers are ASML Holding , British American Tobacco , Intesa Sanpaolo , Roche Holding , Ryanair Holdings , and Unilever .

Top-Performing CEOs and their sectors include:

Matthias Zachert   Lanxess (Germany)   Chemicals
Ivan Glasenberg   Glencore (Switzerland)   Metal & Mining
Anthony Smurfit   Smurfit Kappa (Ireland)   Paper & Packaging
Jacques Aschenbroich   Valeo (France)   Autos & Auto Parts
Carlos Brito   Anheuser-Busch InBev (Belgium)   Beverages
         

Top-Performing CFOs and their sectors include:

Ernesto López Mozo   Ferrovial (Spain)   Building & Construction
Graeme Pitkethly   Unilever (Netherlands)   Food Producers
Adrian Hennah   Reckitt Benckiser Group (United Kingdom)   Household & Personal Care Products
Nicholas Cadbury   Whitbread (United Kingdom)   Leisure & Hotels
Jean-Jacques Guiony   LVMH Moët Hennessy Louis Vuitton (France)   Luxury Goods
         

Will Rowlands-Rees, Managing Director of Research at Institutional Investor , comments, "MiFID II continues to drive the agenda across all parts of the investment community, with corporations no exception. With an expected reduction in sell-side research both produced and consumed starting next year, excellence in IR becomes even more important as IROs and corporate C-suite need to tell their story effectively to the right investors. Mid- and small-cap has become an obvious area of interest for investors, and we're delighted to release our inaugural mid- and small-cap rankings, shining a light on those companies delivering excellence in this area."

With top positions in all four categories, Top-Performing Mid-cap Companies include:

Moncler (Italy) Luxury Goods   Logitech International (Switzerland) Technology/Hardware
Gamesa Corp. Tecnológica (Spain) Capital Goods   Davide Campari-Milano (Italy) Beverages
Tullow Oil (U.K.) Oil & Gas Exploration & Production   Lanxess (Germany) Chemicals
Distribuidora Internacional de Alimentación (Spain) Retailing/Food   Straumann Holding (Switzerland) Medical Technologies & Services
     

For the full list of winners, visit here . The Most Honored Companies from the All-Europe Executive Team rankings will be recognized at a dinner and awards ceremony on June 27 in London.

For more information and complete survey results, please contact Amani Korayeim at amani.korayeim@institutionalinvestor.com or +44 207 779 8535.

About Institutional Investor For 50 years Institutional Investor has consistently distinguished itself among the world's foremost media companies with groundbreaking journalism and incisive writing that provide essential intelligence for a global audience. For more information, visit institutionalinvestor.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Kenmare Resources Welcomes New Dredges to Moma Mine

Updated Category News Views 258

Exciting Developments at the Moma Mine Kenmare Resources plc is a major player in the global mining sector, particularly known for its production of titanium minerals and zircon. Recently, Kenmare achieved a significant milestone with the arrival of its second high-capacity dredge at the Moma Titanium Minerals Mine in northern Mozambique. This advancement represents a...

Continue Reading
Biodesix Reports Strong Q3 2024 Performance and Growth

Updated Category News Views 145

Strong Quarterly Results for Biodesix Biodesix, Inc. (NASDAQ: BDSX), a leader in diagnostic solutions, recently announced impressive financial results for its third quarter, showing remarkable growth compared to the previous year. The company achieved a revenue of $18.2 million, representing a significant 35% increase over Q3 2023. Furthermore, Biodesix's gross profit...

Continue Reading
Innovative Changes at Health In Tech to Boost AI and Revenue

Updated Category News Views 127

Health In Tech Announces Key Leadership Changes Health In Tech (NASDAQ: HIT), a prominent Insurtech platform company known for its innovative third-party AI technology, has implemented significant leadership changes aimed at reinforcing its AI capabilities and propelling company growth. This strategic move is expected to position the company more competitively in the...

Continue Reading
Urgent Notice for KinderCare Learning Investors: Act Now!

Updated Category News Views 169

Important Alert for KinderCare Learning Investors KinderCare Learning Companies, Inc. (NYSE: KLC) is under scrutiny following a significant decline in its stock prices attributed to serious allegations about the company’s operations. The Allegations: What We Know The company conducted its IPO in 2024, offering more than 27 million shares at $24 per share. However,...

Continue Reading
Replimune Group Faces Class Action Lawsuit - Key Details

Updated Category News Views 148

Replimune Group, Inc. Faces Legal Action Replimune Group, Inc. has recently come under the scrutiny of a class action securities lawsuit. This legal action is initiated by Levi & Korsinsky, a law firm known for its role in securities litigation. The lawsuit targets investors who may have experienced losses due to alleged misleading information regarding the company's...

Continue Reading